Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy Regimens in Locally Advanced Breast Cancer
NCT03349177Phase 3Unknown
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of fluorouracil, epirubicin, cyclophosphamide, docetaxel in breast cancer. Status: unknown.
02
Drugs
fluorouracilepirubicincyclophosphamidedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03349177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349177.